Literature DB >> 35442232

Ferret Lung Transplantation Models Differential Lymphoid Aggregate Morphology Between Restrictive and Obstructive Forms of Chronic Lung Allograft Dysfunction.

Thomas J Lynch1, Bethany A Ahlers1, Anthony M Swatek1, Vitaly Ievlev2, Albert C Pai1, Leonard Brooks1, Yinghua Tang2, Idil A Evans2, David K Meyerholz3, John F Engelhardt2, Kalpaj R Parekh1.   

Abstract

BACKGROUND: Long-term survival after lung transplantation remains limited by chronic lung allograft dysfunction (CLAD). CLAD has 2 histologic phenotypes, namely obliterative bronchiolitis (OB) and restrictive alveolar fibroelastosis (AFE), which have distinct clinical presentations, pathologies, and outcomes. Understanding of OB versus AFE pathogenesis would improve with better animal models.
METHODS: We utilized a ferret orthotopic single-lung transplantation model to characterize allograft fibrosis as a histologic measure of CLAD. Native lobes and "No CLAD" allografts lacking aberrant histology were used as controls. We used morphometric analysis to evaluate the size and abundance of B-cell aggregates and tertiary lymphoid organs (TLOs) and their cell composition. Quantitative RNA expression of 47 target genes was performed simultaneously using a custom QuantiGene Plex Assay.
RESULTS: Ferret lung allografts develop the full spectrum of human CLAD histology including OB and AFE subtypes. While both OB and AFE allografts developed TLOs, TLO size and number were greater with AFE histology. More activated germinal center cells marked by B-cell lymphoma 6 Transcription Repressor, (B-cell lymphoma 6) expression and fewer cells expressing forkhead box P3 correlated with AFE, congruent with greater diffuse immunoglobulin, plasma cell abundance, and complement 4d staining. Furthermore, forkhead box P3 RNA induction was significant in OB allografts specifically. RNA expression changes were seen in native lobes of animals with AFE but not OB when compared with No CLAD native lobes.
CONCLUSIONS: The orthotopic ferret single-lung transplant model provides unique opportunities to better understand factors that dispose allografts to OB versus AFE. This will help develop potential immunomodulatory therapies and antifibrotic approaches for lung transplant patients.
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35442232      PMCID: PMC9529760          DOI: 10.1097/TP.0000000000004148

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   5.385


  69 in total

1.  Outcomes in Solid-Organ Transplantation: Success and Stagnation.

Authors:  Abbas Rana; Elizabeth Louise Godfrey
Journal:  Tex Heart Inst J       Date:  2019-02-01

Review 2.  The collaborative transplant study registry.

Authors:  Gerhard Opelz; Bernd Döhler; Andrea Ruhenstroth; Sofia Cinca; Christian Unterrainer; Lilli Stricker; Sabine Scherer; Petra Gombos; Caner Süsal; Volker Daniel; Hien Tran
Journal:  Transplant Rev (Orlando)       Date:  2013-03-05       Impact factor: 3.943

3.  A Universal Influenza Vaccine: The Strategic Plan for the National Institute of Allergy and Infectious Diseases.

Authors:  Emily J Erbelding; Diane J Post; Erik J Stemmy; Paul C Roberts; Alison Deckhut Augustine; Stacy Ferguson; Catharine I Paules; Barney S Graham; Anthony S Fauci
Journal:  J Infect Dis       Date:  2018-07-02       Impact factor: 5.226

4.  High-throughput immunophenotyping of 43 ferret lymphomas using tissue microarray technology.

Authors:  A S Hammer; B Williams; H H Dietz; S J Hamilton-Dutoit
Journal:  Vet Pathol       Date:  2007-03       Impact factor: 2.221

Review 5.  B Cell Responses: Cell Interaction Dynamics and Decisions.

Authors:  Jason G Cyster; Christopher D C Allen
Journal:  Cell       Date:  2019-04-18       Impact factor: 41.582

6.  IL-22 is required for the induction of bronchus-associated lymphoid tissue in tolerant lung allografts.

Authors:  Satona Tanaka; Jason M Gauthier; Anja Fuchs; Wenjun Li; Alice Y Tong; Margaret S Harrison; Ryuji Higashikubo; Yuriko Terada; Ramsey R Hachem; Daniel Ruiz-Perez; Jon H Ritter; Marina Cella; Marco Colonna; Isaiah R Turnbull; Alexander S Krupnick; Andrew E Gelman; Daniel Kreisel
Journal:  Am J Transplant       Date:  2019-12-09       Impact factor: 8.086

Review 7.  Lymphoid Neogenesis and Tertiary Lymphoid Organs in Transplanted Organs.

Authors:  Alice Koenig; Olivier Thaunat
Journal:  Front Immunol       Date:  2016-12-27       Impact factor: 7.561

Review 8.  Chronic Inflammation: A Common Promoter in Tertiary Lymphoid Organ Neogenesis.

Authors:  Shanshan Luo; Rui Zhu; Ting Yu; Heng Fan; Yu Hu; Sarajo Kumar Mohanta; Desheng Hu
Journal:  Front Immunol       Date:  2019-12-18       Impact factor: 7.561

9.  Circulating exosomes with lung self-antigens as a biomarker for chronic lung allograft dysfunction: A retrospective analysis.

Authors:  Monal Sharma; Muthukumar Gunasekaran; Ranjithkumar Ravichandran; Cynthia E Fisher; Ajit P Limaye; Chengcheng Hu; John McDyer; Vaidehi Kaza; Ankit Bharat; Sofya Tokman; Ashraf Omar; Ashwini Arjuna; Rajat Walia; Ross M Bremner; Michael A Smith; Ramsey R Hachem; Thalachallour Mohanakumar
Journal:  J Heart Lung Transplant       Date:  2020-07-07       Impact factor: 10.247

Review 10.  Tertiary Lymphoid Structures: Autoimmunity Goes Local.

Authors:  Elena Pipi; Saba Nayar; David H Gardner; Serena Colafrancesco; Charlotte Smith; Francesca Barone
Journal:  Front Immunol       Date:  2018-09-12       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.